Is Altamira Therapeutics Ltd. (CYTO) a Buy, Sell, or Hold?
NASDAQ : CYTO
Altamira Therapeutics Ltd. — Institutional Ownership
$0.3 USD
$0.3 (0%)
- Volume
- 724.3K
- Average Volume
- 244.02K
- Market Capitalization
- $1.13M
- P/E Ratio
- -0.02
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.42
- Year Low
- $0.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.32
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-05-15 | Armistice Capital, LLC | 473.87K | 9.99% |
| 2025-05-06 | Thomas Meyer | 1.08M | 18.90% |
| 2025-02-14 | Armistice Capital, LLC | 478.55K | 9.99% |
| 2024-11-14 | Armistice Capital, LLC | 408.11K | 9.99% |
| 2024-11-14 | Steven Boyd | 408.11K | 9.99% |
| 2022-05-13 | Meyer | 1.16M | 7.40% |
| 2021-05-21 | Meyer | 817.26K | 6.30% |
| 2021-02-12 | Altium Capital Management, LP | - | 0.00% |
| 2021-02-12 | Altium Growth GP, LLC | - | 0.00% |
| 2021-02-12 | Altium Growth Fund, LP | - | 0.00% |
| 2020-12-07 | Meyer | 660.52K | 5.70% |
| 2020-08-20 | Meyer | 532.91K | 8.00% |
| 2020-02-14 | Altium Growth Fund, LP | 897.44K | 9.90% |
| 2020-02-14 | Altium Capital Management, LP | 897.44K | 9.90% |
| 2020-02-14 | Altium Growth GP, LLC | 897.44K | 9.90% |
| 2019-05-23 | Altium Capital Management, LP | 897.44K | 9.90% |
| 2019-05-23 | Altium Growth GP, LLC | 897.44K | 9.90% |
| 2019-05-23 | Altium Growth Fund, LP | 897.44K | 9.90% |
| 2019-02-15 | S | 420K | 1.20% |
| 2019-02-14 | EIN: 98-1028040 | 331.15K | 0.88% |
| 2019-02-14 | Sofinnova Partners SAS, a French corporation (“SP SAS”) | 331.15K | 0.88% |
| 2019-02-14 | Denis Lucquin (“Lucquin”) | 331.15K | 0.88% |
| 2019-02-15 | S | 420K | 1.20% |
| 2019-02-14 | Monique Saulnier (“Saulnier”) | 331.15K | 0.88% |
| 2019-02-14 | Graziano Seghezzi (“Seghezzi”) | 331.15K | 0.88% |
| 2019-02-15 | S | 420K | 1.20% |
| 2019-02-14 | Antoine Papiernik (“Papiernik”) | 331.15K | 0.88% |
| 2019-02-14 | Henrijette Richter (“Richter”) | 331.15K | 0.88% |
| 2018-08-10 | S | 2.05M | 8.30% |
| 2018-08-10 | S | 2.05M | 8.30% |
| 2018-08-10 | S | 2.05M | 8.30% |
| 2018-08-09 | Morgan Stanley | 261.43K | 1.00% |
| 2018-08-09 | Morgan Stanley Capital Services LLC | 260.29K | 1.00% |
| 2018-05-24 | Dr. Anand Mehra (“Mehra”) | 258.53K | 4.10% |
| 2018-05-24 | Dr. Michael F. Powell (“Powell”) | 258.53K | 4.10% |
| 2018-05-24 | VIII”) | 258.53K | 4.10% |
| 2018-05-24 | Dr. James I. Healy (“Healy”) | 259.92K | 4.20% |
| 2018-05-24 | Sofinnova Venture Partners VIII, L.P. (“SVP VIII”) | 258.53K | 4.10% |
| 2018-05-17 | Morgan Stanley | 325.82K | 5.30% |
| 2018-05-17 | Morgan Stanley Capital Services LLC | 324.68K | 5.30% |
| 2018-02-14 | 10. | 21.95M | 4.50% |
| 2018-02-14 | 10. | 2.17M | 4.50% |
| 2018-02-14 | 4.5% | 2.17M | 4.50% |
| 2018-01-16 | Management, LP | 1.75M | 3.80% |
| 2018-01-16 | Hoe | 1.75M | 3.80% |
| 2018-01-16 | Ryan M. Lane | 1.75M | 3.80% |
| 2017-02-17 | Martin D. Hoe | 1.75M | 5.64% |
| 2017-02-17 | Empery Asset Management, LP | 1.75M | 5.64% |
| 2017-02-17 | Ryan M. Lane | 1.75M | 5.64% |
| 2017-02-14 | Abigail P. Johnson | - | 0.00% |
| 2017-02-14 | FMR LLC | - | 0.00% |
| 2017-02-07 | Sofinnova Management VIII, L.L.C. (“SM VIII”) | 5.82M | 17.00% |
| 2017-02-07 | Dr. James I. Healy (“Healy”) | 5.83M | 17.00% |
| 2017-02-07 | Dr. Michael F. Powell (“Powell”) | 5.82M | 17.00% |
| 2017-02-07 | Dr. Anand Mehra (“Mehra”) | 5.82M | 17.00% |
| 2017-02-07 | Sofinnova Venture Partners VIII, L.P. (“SVP VIII”) | 5.82M | 17.00% |
| 2016-07-14 | 6.3 | 2.17M | 6.30% |
| 2016-07-14 | 10. | 2.17M | 6.30% |
| 2016-07-14 | 10. | 21.95M | 6.40% |
| 2016-02-12 | OF ABOVE PERSONS ( | 1.55M | 4.50% |
| 2016-02-12 | 10. | 2.17M | 6.30% |
| 2015-05-14 | 10. | 2.17M | 7.50% |
| 2015-05-14 | 7.6% | 21.95M | 7.60% |
| 2015-02-13 | NAME OF REPORTING | 2.17M | 7.50% |
| 2015-02-13 | NAME OF REPORTING | 2.17M | 7.50% |
| 2015-02-13 | NAME OF REPORTING | 2.17M | 7.50% |
| 2015-02-13 | 10. | 2.17M | 7.50% |
| 2015-02-13 | Edward C. Johnson 3d | 1.67M | 5.76% |
| 2015-02-13 | FMR LLC | 1.67M | 5.76% |
| 2015-02-13 | 7.6% | 21.95M | 7.60% |
| 2015-02-13 | Abigail P. Johnson | 1.67M | 5.76% |
| 2014-08-13 | Sofinnova Venture Partners VIII, L.P. (“SVP VIII”) | 5.82M | 20.60% |
| 2014-08-13 | Sofinnova Management VIII, L.L.C. (“SM VIII”) | 5.82M | 20.60% |
| 2014-08-13 | Dr. James I. Healy (“Healy”) | 5.82M | 20.60% |
| 2014-08-13 | Dr. Anand Mehra (“Mehra”) | 5.82M | 20.60% |
| 2014-08-13 | Dr. Michael F. Powell (“Powell”) | 5.82M | 20.60% |
| 2014-08-13 | Dr. Srinivas Akkaraju (“Akkaraju”) | 5.82M | 20.60% |
CYTO Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.11 | 491K | $54255.5 | $998.62K | $361.05K | -$583.32K |
| 2023-12-31 | $2.93 | 491K | $1.44M | $617.41K | $99659 | $918.84K |
| 2022-12-31 | $89.64 | 45536 | $4.08M | $15395 | $6.33M | $10.4M |
| 2021-12-31 | $661.87 | 33116 | $21.92M | $984.19K | $575.74K | $21.51M |
| 2020-12-31 | $928.09 | 15035 | $13.95M | $11.26M | $523.92K | $3.22M |
| 2019-12-31 | $626.70 | 14545 | $9.12M | $1.38M | -$ | $7.73M |
| 2018-12-31 | $3589.08 | 3975 | $14.27M | $5.39M | $1.44M | $10.31M |
| 2017-12-31 | $48297.01 | 1093 | $52.79M | $14.97M | $10.13M | $47.94M |
| 2016-12-31 | $87105.70 | 858 | $74.74M | $32.44M | $12.36M | $54.66M |
| 2015-12-31 | $390988.75 | 807 | $315.53M | $50.24M | -$ | $265.29M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.11 | 491K | $54255.5 | $998.62K | $361.05K | -$583.32K |
| 2024-06-30 | $1.22 | 491K | $599.02K | $65455 | $427.44K | $961K |
| 2023-12-31 | $2.93 | 209.96K | $614.3K | $617.41K | $99659 | $96545 |
| 2023-09-30 | $4.47 | 209.96K | $939.35K | $617.41K | -$ | $321.94K |
| 2023-06-30 | $11.47 | 209.96K | $2.41M | $49569 | $3.47M | $5.83M |
| 2023-03-31 | $23.42 | 209K | $4.9M | $49569 | $3.35M | $8.19M |
| 2022-12-31 | $89.64 | 277.08K | $24.84M | $15395 | $6.33M | $31.15M |
| 2022-09-30 | $114.46 | 48088 | $5.5M | $15395 | $6.21M | $11.7M |
| 2022-06-30 | $185.22 | 38744 | $7.18M | $372.65K | $5.22M | $12.02M |
| 2022-03-31 | $405.92 | 38744 | $15.73M | $372.65K | $5.1M | $20.46M |
| 2021-12-31 | $661.87 | 31647 | $20.95M | $984.19K | $575.74K | $20.54M |
| 2021-09-30 | $748.89 | 34364 | $25.73M | $984.19K | $461.48K | $25.21M |